Use of 4-(pyrrolidin-1-yl)quinoline compounds to kill clinically latent microorganisms
US8759348B2 · kind B2 · utility
0Cited by
2References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 16, 2008 |
| Grant date | Jun 24, 2014 |
| Priority date | — |
| Expiry date | Nov 26, 2029 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
There is provided the use of compounds of formula wherein R1, R2, R3 and E have meanings given in the description, for the preparation of a medicament for killing clinically latent microorganisms. There is also provided the use of compounds of formula I for treating microbial infections, as well as certain compounds of formula (I) per se.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.